IEFM
PRME icon

IQ EQ Fund Management’s Prime Medicine PRME Stock Holding History

IQ EQ Fund Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$715K Buy
205,389
+26,870
+15% +$102K 0.05% 231
2025
Q4 		$619K Buy
178,519
+57,746
+48% +$257K 0.04% 241
2025
Q3 		$669K Buy
120,773
+87,113
+259% +$354K 0.05% 244
2025
Q2 		$83.1K Sell
33,660
-56,210
-63% -$86.6K 0.01% 305
2025
Q1 		$179K Buy
89,870
+29,185
+48% +$74.5K 0.02% 286
2024
Q4 		$177K Buy
60,685
+32,572
+116% +$114K 0.02% 274
2024
Q3 		$109K Buy
28,113
+9,199
+49% +$42.6K 0.01% 315
2024
Q2 		$97.2K Buy
+18,914
New +$115K 0.01% 302

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

IQ EQ Fund Management's PRME Position: Q1 2026 in Review

IQ EQ Fund Management increased its Prime Medicine (PRME) stake by 15% in Q1 2026, buying an estimated $102K and bringing the position to 205,389 shares worth $715K. The position accounts for 0.05% of the portfolio, ranked #231.

IQ EQ Fund Management first reported a position in PRME in Q2 2024 and has held it in 8 quarters since. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • IQ EQ Fund Management held 205,389 shares of Prime Medicine worth $715K as of Q1 2026.
  • IQ EQ Fund Management bought 26,870 Prime Medicine shares in Q1 2026, an estimated $102K.
  • Prime Medicine made up 0.05% of IQ EQ Fund Management's portfolio in Q1 2026, its #231 holding.
  • IQ EQ Fund Management first reported a position in Prime Medicine in Q2 2024 and has held it in 8 quarters since.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on IQ EQ Fund Management's 13F filing for Q1 2026, filed 11 May 2026.